US Broker Ratings

Danaher Corporation (DHR) Stock Analysis: Exploring a 20% Upside in the Healthcare Sector

Danaher Corporation (NYSE: DHR), a major player in the healthcare sector, continues to capture the interest of investors with its robust market presence in the diagnostics and research industry. With..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Investor Insights on a Biotech Giant with 28% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, where its innovative approach to drug development continues to captivate investors and analysts alike. Headquartered in..

Mettler-Toledo (MTD) Stock Analysis: Evaluating Market Position Amidst Challenging Growth Dynamics

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the healthcare sector specializing in diagnostics and research, stands as a significant force in the precision instruments market. With a market..

Centene Corporation (CNC) Stock Analysis: Exploring a 56% Potential Upside Amid Healthcare Sector Volatility

Centene Corporation (NYSE: CNC), a significant player in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to healthcare plans. With a market capitalization of $13.94 billion, Centene..

STERIS plc (STE) Stock Analysis: Healthcare Giant with a 16.51% Potential Upside

STERIS plc (NYSE: STE), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects. With a market capitalization of $22.67..

Biogen Inc. (BIIB) Investor Outlook: Potential Upside of Over 28% Amidst Diverse Therapeutic Portfolio

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, stands out with its robust therapeutic portfolio targeting neurological and neurodegenerative diseases. With a market cap of $19.27 billion, Biogen..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a Potential 41.79% Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the global healthcare sector, specializes in the development, manufacturing, and distribution of generic and specialty medicines. With its headquarters in..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 14.80% Upside with Strong Buy Consensus

Alcon Inc. (NYSE: ALC), a significant player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its robust portfolio in the eye care..

Waters Corporation (WAT) Stock Analysis: Exploring a 23.45% Potential Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $18.03 billion, Waters is a..

Zoetis Inc. (ZTS) Investor Outlook: A 27.60% Potential Upside in the Animal Health Market

Zoetis Inc. (NYSE: ZTS), a leading player in the animal health industry, continues to capture investor attention with a promising potential upside of 27.60% based on current analyst ratings. With..

Abbott Laboratories (ABT) Stock Analysis: Healthcare Giant Poised for 12.6% Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector with a market capitalization of $220.16 billion, is capturing the attention of investors with its robust portfolio and promising stock..

Amgen Inc. (AMGN) Stock Analysis: Navigating a 2.25% Potential Upside in the Healthcare Sector

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to captivate investor interest with its robust portfolio of human therapeutics and a market capitalization of $164.85 billion. With..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating a 7.57% Potential Upside Amid Innovations in Biotechnology

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a prominent player in the biotechnology sector, continues to capture investor attention with its innovative approach to treating cystic fibrosis (CF) and other serious diseases...

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 12.43% Upside Potential in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the medical instruments and supplies industry, presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s resilience. With..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Navigating Healthcare Innovation with a 6.28% Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a staggering market capitalization of $33.86 billion, this..

GSK plc (GSK) Investor Outlook: Exploring a 8.89% Upside Potential

GSK plc (NYSE: GSK), a stalwart in the global healthcare sector, continues to capture investor interest with its robust portfolio and a potential upside of 8.89%. With a market capitalization..

argenx SE (ARGX) Stock Analysis: Exploring a 28.49% Potential Upside with Strong Buy Ratings

argenx SE (ARGX), a commercial-stage biopharmaceutical company headquartered in Amsterdam, Netherlands, is generating significant buzz in the biotechnology sector. With a market capitalization of $36.23 billion, argenx stands as a..

Cencora, Inc. (COR) Stock Analysis: A 13.33% Upside Potential with Robust Growth in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a titan in the medical distribution sector, presents a compelling case for investors seeking exposure to the healthcare industry. With a market capitalization of $56.28 billion,..

Medtronic plc (MDT) Stock Analysis: Evaluating Growth Potential in the Medical Devices Sector

Medtronic plc (NYSE: MDT), a prominent player in the medical devices industry, offers an intriguing investment opportunity for those eyeing the healthcare sector. As a leader in device-based medical therapies,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Insight into Its Investment Potential and Growth Prospects

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, continues to capture investor interest with its robust pipeline of biopharmaceutical products. As the company stands at a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds